EN Official Journal of the European Union L 261/5

COMMISSION REGULATION (EU) No 944/2013

of 2 October 2013

amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (1), and in particular Article 37(5) and Article 53 thereof,

Whereas:

(1) In respect of precautionary statement P210 set out in table 6.2 Part 1 of Annex IV to Regulation (EC) No 1272/2008 the 5th revision of the Globally Harmonised System of Classification and Labelling of Chemicals (hereinafter ‘GHS’) of the United Nations has brought about changes which were not fully taken into account in Commission Regulation (EU) No 487/2013 (2). For reasons of consistency it is necessary to provide for full alignment between the GHS and Regulation (EC) No 1272/2008.

(2) Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains two lists of harmonised classification and labelling of hazardous substances. Table 3.1 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Parts 2 to 5 of Annex I to Regulation (EC) No 1272/2008. Table 3.2 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Annex VI to Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (3). Those two lists need to be amended to include updated classifications for substances already subject to those harmonised classifications and to include new harmonised classifications.

(3) The Committee for Risk Assessment (RAC) of the European Chemicals Agency (ECHA) has issued opinions on proposals for harmonised classification and labelling of substances which had been submitted to ECHA pursuant to Article 37 of Regulation (EC) No 1272/2008. Based on those opinions, as well as on the comments received from the parties concerned, it is appropriate to amend Annex VI to Regulation (EC) No 1272/2008 in order to harmonise the classification and labelling of certain substances.

(4) The harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, should not apply immediately, as a certain period of time will be necessary to allow operators to adapt the labelling and packaging of substances and mixtures to the new classifications and to sell existing stocks. In addition, a certain period of time will be necessary to allow operators to comply with the registration obligations resulting from the new harmonised classifications for substances classified as carcinogenic, mutagenic or toxic to reproduction, categories 1A and 1B (Table 3.1) and categories 1 and 2 (Table 3.2), or as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 23 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (4).

(5) With regard to the substance pitch, coal tar, high-temp. (EC Number: 266-028-2), an extended period of time will be necessary to allow operators to comply with the obligations resulting from the new harmonised classification for substances classified as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 3 and Annex III of Directive 2008/68/EC of the European Parliament and of the Council of 24 September 2008 on the inland transport of dangerous goods (5). Therefore, a longer transition time should be foreseen before the harmonised classification has to be applied.

(6) With regard to the substance gallium arsenide (EC Number: 215-114-8), the RAC is in the process of adopting a new opinion for the hazard class ‘toxicity to reproduction’. Therefore, this hazard class should not be included in Annex VI to Regulation (EC) No 1272/2008 until that opinion is finalised.

(7) With regard to the substance polyhexamethylene biguanide hydrochloride (CAS number 27083-27-8 or 32289-58-0), new scientific data has been made available for the hazard class ‘acute toxicity (inhalation)’, which suggests that the classification for this hazard class as recommended in the RAC opinion, which is based on older data, might not be appropriate. Therefore, this hazard class should not be included in Annex VI to Regulation (EC) No 1272/2008 until RAC has had the opportunity to deliver an opinion on the new information, while all other hazard classes covered by the earlier RAC opinion should be included.

(8) In line with the transitional provisions of Regulation (EC) No 1272/2008 which allow the application of the new provisions at an earlier stage on a voluntary basis, suppliers should have the possibility of applying the harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, and of adapting the labelling and packaging accordingly on a voluntary basis before the dates by which the harmonised classifications will become mandatory.

(9) The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006,

HAS ADOPTED THIS REGULATION:

Article 1

Regulation (EC) No 1272/2008 is amended as follows:

(1) Annex IV is amended in accordance with the Annex I to this Regulation;

(2) Part 3 of Annex VI is amended as follows: (a) Table 3.1 is amended as follows: (i) The entries set out in Annex VI to Regulation (EC) No 1272/2008 corresponding to the entries set out in Annex II to this Regulation are replaced by the entries set out in Annex II to this Regulation; (ii) The entries set out in Annex III to this Regulation are inserted in accordance with the order of the entries set out in Table 3.1. (b) Table 3.2 is amended as follows: (i) The entries set out in Annex VI to Regulation (EC) No 1272/2008 corresponding to the entries set out in Annex IV to this Regulation are replaced by the entries set out in in Annex IV to this Regulation; (ii) The entries set out in Annex V to this Regulation are inserted in accordance with the order of the entries set out in Table 3.2.

Article 2

1. By way of derogation from Article 3(2) substances and mixtures may, before 1 December 2014 and 1 June 2015 respectively, be classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008 as amended by this Regulation.

2. By way of derogation from Article 3(2), substances classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008 and placed on the market before 1 December 2014, shall not be required to be relabelled and repackaged in accordance with Regulation (EC) No 1272/2008 as amended by this Regulation until 1 December 2016.

3. By way of derogation from Article 3(2) mixtures classified, labelled and packaged in accordance with Directive 1999/45/EC of the European Parliament and of the Council (6) or Regulation (EC) No 1272/2008 and placed on the market before 1 June 2015, shall not be required to be relabelled and repackaged in accordance with Regulation (EC) No 1272/2008 as amended by this Regulation until 1 June 2017.

4. By way of derogation from Article 3(3) the harmonised classifications set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008, as amended by this Regulation, may be applied before the dates referred to in Article 3(3).

Article 3

1. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

2. Article 1(1) shall apply in respect of substances from 1 December 2014 and in respect of mixtures from 1 June 2015.

3. Article 1(2) shall apply from 1 January 2015 for all entries except for the entry pitch, coal tar, high-temp. (EC Number 266-028-2), for which Article 1 shall apply from 1 April 2016.

This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 2 October 2013. For the Commission The President José Manuel BARROSO

(1) OJ L 353, 31.12.2008, p. 1.

(2) OJ L 149, 1.6.2013, p. 1.

(3) OJ 196, 16.8.1967, p. 1.

(4) OJ L 396, 30.12.2006, p. 1.

(5) OJ L 260, 30.9.2008, p. 13.

(6) OJ L 200, 30.7.1999, p. 1.

ANNEX I In Part 1, Table 6.2 of Annex IV to Regulation (EC) No 1272/2008, Code P210 is replaced by the following: ‘P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Explosives (section 2.1) Divisions 1.1, 1.2, 1.3, 1.4, 1.5 Flammable gases (section 2.2) 1, 2 Aerosols (section 2.3) 1, 2, 3 Flammable liquids (section 2.6) 1, 2, 3 Flammable solids (section 2.7) 1, 2 Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F Pyrophoric liquids (section 2.9) 1 Pyrophoric solids (section 2.10) 1 Oxidising liquids (section 2.13) 1, 2, 3 Oxidising solids (section 2.14) 1, 2, 3 Organic peroxides (section 2.15) Types A, B, C, D, E, F’

ANNEX II Index No International Chemical Identification EC No CAS No Classification Labelling Specific Conc. Limits, M — Factors Notes Hazard Class and Category Code(s) Hazard statement Code(s) Pictogram, Signal Word Code(s) Hazard statement Code(s) Suppl. Hazard statement Code(s) 015-004-00-8 aluminium phosphide 244-088-0 20859-73-8 Water-react. 1 H260 GHS02 H260 EUH029 M = 100 Acute Tox. 2 H300 GHS06 H300 EUH032 Acute Tox. 3 H311 GHS09 H311 Acute Tox. 1 H330 Dgr H330 Aquatic Acute 1 H400 H400 015-005-00-3 magnesium phosphide; trimagnesium diphosphide 235-023-7 12057-74-8 Water-react. 1 H260 GHS02 H260 EUH029 M = 100 Acute Tox. 2 H300 GHS06 H300 EUH032 Acute Tox. 3 H311 GHS09 H311 Acute Tox. 1 H330 Dgr H330 Aquatic Acute 1 H400 H400 015-123-00-5 fenamiphos (ISO); ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate 244-848-1 22224-92-6 Acute Tox. 2 H300 GHS06 H300 M = 100 M = 100 Acute Tox. 2 H310 GHS09 H310 Acute Tox. 2 H330 Dgr H330 Eye Irrit. 2 H319 H319 Aquatic Acute 1 H400 Aquatic Chronic 1 H410 H410 030-012-00-1 aluminium-magnesium-zinc-carbonate-hydroxide 423-570-6 169314-88-9 Aquatic Chronic 4 H413 H413 602-006-00-4 chloroform; trichloromethane 200-663-8 67-66-3 Carc. 2 H351 GHS06 H351 Repr. 2 H361d GHS08 H361d Acute Tox. 3 H331 Dgr H331 Acute Tox. 4 H302 H302 STOT RE 1 H372 H372 Eye Irrit. 2 H319 H319 Skin Irrit. 2 H315 H315 603-097-00-3 1,1’,1’-nitrilotripropan-2-ol; triisopropanolamine 204-528-4 122-20-3 Eye Irrit. 2 H319 GHS07 Wng H319 605-008-00-3 acrolein; prop-2-enal; acrylaldehyde 203-453-4 107-02-8 Flam. Liq. 2 H225 GHS02 H225 EUH071 Skin Corr. 1; H314: C ≥ 0,1 % D Acute Tox. 1 H330 GHS06 H330 Acute Tox. 2 H300 GHS05 H300 Acute Tox. 3 H311 GHS09 H311 Skin Corr. 1 H314 Dgr H314 Aquatic Acute 1 H400 M = 100 Aquatic Chronic 1 H410 H410 M = 1 607-023-00-0 vinyl acetate 203-545-4 108-05-4 Flam. Liq. 2 H225 GHS02 H225 D Carc. 2 H351 GHS08 H351 Acute Tox. 4 H332 GHS07 H332 STOT SE 3 H335 Dgr H335 607-613-00-8 reaction mass of: succinic acid monopersuccinic acid dipersuccinic acid monomethyl ester of succinic acid monomethyl ester of persuccinic acid dimethyl succinate glutaric acid monoperglutaric acid diperglutaric acid monomethyl ester of glutaric acid monomethyl ester of perglutaric acid dimethyl glutarate adipic acid monoperadipic acid diperadipic acid monomethyl ester of adipic acid monomethyl ester of peradipic acid dimethyl adipate hydrogen peroxide methanol water 432-790-1 Acute Tox. 4* H332 GHS07 H332 Acute Tox. 4* H312 GHS05 H312 Acute Tox. 4* H302 GHS08 H302 Skin Corr. 1B H314 Dgr H314 STOT SE 2 H371 (eyes) H371 (eyes) 609-003-00-7 nitrobenzene 202-716-0 98-95-3 Carc. 2. H351 GHS06 H351 Repr. 1B H360F GHS08 H360F Acute Tox. 3 H301 Dgr H301 Acute Tox. 3 H331 H331 Acute Tox. 3 H311 H311 STOT RE 1 H372 (blood) H372 (blood) Aquatic Chronic 3 H412 H412 612-120-00-6 aclonifen (ISO); 2-chloro-6-nitro-3-phenoxyaniline 277-704-1 74070-46-5 Carc. 2 H351 GHS08 H351 M = 100 M = 10 Skin Sens. 1A H317 GHS07 H317 Aquatic Acute 1 H400 GHS09 Aquatic Chronic 1 H410 Wng H410 613-175-00-9 epoxiconazole (ISO); (2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[( 1H-1,2,4-triazol-1-yl)methyl]oxirane 406-850-2 133855-98-8 Carc. 2 H351 GHS08 H351 Repr. 1B H360Df GHS09 H360Df Aquatic Chronic 2 H411 Dgr H411 616-200-00-1 reaction mass of N,N’-ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide) 432-430-3 Aquatic Chronic 4 H413 H413 648-055-00-5 pitch, coal tar, high-temp.; [The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] 266-028-2 65996-93-2 Carc. 1A H350 GHS08 H350 M = 1000 M = 1000 Muta. 1B H340 GHS09 H340 Repr. 1B H360FD Dgr H360FD Aquatic Acute 1 H400 Aquatic Chronic 1 H410 H410 649-330-00-2 naphtha (petroleum), hydrodesulphurized heavy; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).] 265-185-4 64742-82-1 Carc. 1B H350 GHS08 H350 P Muta. 1B H340 Dgr H340 STOT RE 1 H372 (central nervous system) H372 (central nervous system) Asp. Tox. 1 H304 H304 649-345-00-4 stoddard solvent; Low boiling point naphtha — unspecified; [A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).] 232-489-3 8052-41-3 Carc. 1B H350 GHS08 H350 P Muta. 1B H340 Dgr H340 STOT RE 1 H372 (central nervous system) H372 (central nervous system) Asp. Tox. 1 H304 H304 649-405-00-X solvent naphtha (petroleum), medium aliph.; Straight run kerosine; [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).] 265-191-7 64742-88-7 STOT RE 1 H372 (central nervous system) GHS08 H372 (central nervous system) Asp. Tox. 1 H304 Dgr H304

ANNEX III Index No International Chemical Identification EC No CAS No Classification Labelling Specific Conc. Limits, M — Factors Notes Hazard Class and Category Code(s) Hazard statement Code(s) Pictogram, Signal Word Code(s) Hazard statement Code(s) Suppl. Hazard statement Code(s) 031-001-00-4 gallium arsenide 215-114-8 1303-00-0 Carc. 1B H350 GHS08 H350 STOT RE 1 H372 (respiratory and haematopoietic systems) Dgr H372 (respiratory and haematopoietic systems) 050-025-00-6 trichloromethylstannane 213-608-8 993-16-8 Repr. 2 H361d GHS08 Wng H361d 050-026-00-1 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate 260-828-5 57583-34-3 Repr. 2 H361d GHS08 Wng H361d 050-027-00-7 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate 239-622-4 15571-58-1 Repr. 1B H360D GHS08 Dgr H360D 601-087-00-3 2,4,4-trimethylpentene 246-690-9 25167-70-8 Flam. Liq. 2 H225 GHS02 H225 D Asp. Tox. 1 H304 GHS07 H304 STOT SE 3 H336 GHS08 Dgr H336 606-145-00-1 sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione 99105-77-8 Repr. 2 H361d GHS08 H361d M = 1 M = 10 STOT RE 2 H373 (kidneys) GHS07 H373 (kidneys) Skin Sens. 1A H317 GHS09 H317 Aquatic Acute 1 H400 Wng Aquatic Chronic 1 H410 H410 607-699-00-7 bifenthrin (ISO); (2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate 82657-04-3 Carc. 2 H351 GHS06 H351 M = 10 000 M = 100 000 Acute Tox. 3 H331 GHS08 H331 Acute Tox. 2 H300 GHS09 H300 STOT RE 1 H372 (nervous system) Dgr H372 (nervous system) Skin Sens. 1B H317 H317 Aquatic Acute 1 H400 Aquatic Chronic 1 H410 H410 607-700-00-0 indoxacarb (ISO); methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1] 173584-44-6 [1] Acute Tox. 3 H301 GHS06 H301 M = 1 M = 1 Acute Tox. 4 H332 GHS08 H332 STOT RE 1 H372 (blood, nervous system, heart) GHS09 H372 (blood, nervous system, heart) Skin Sens. 1B H317 Dgr H317 Aquatic Acute 1 H400 Aquatic Chronic 1 H410 H410 reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25; methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2] 144171-61-9 [2] 607-702-00-1 dihexyl phthalate 201-559-5 84-75-3 Repr. 1B H360FD GHS08 Dgr H360FD 607-703-00-7 ammoniumpentadeca- fluorooctanoate 223-320-4 3825-26-1 Carc. 2 H351 GHS08 H351 Repr. 1B H360D GHS07 H360D Lact. H362 GHS05 H362 Acute Tox. 4 H332 Dgr H332 Acute Tox. 4 H302 H302 STOT RE 1 H372 (liver) H372 (liver) Eye Dam.1 H318 H318 607-704-00-2 perfluorooctanoic acid 206-397-9 335-67-1 Carc. 2 H351 GHS08 H351 Repr. 1B H360D GHS07 H360D Lact. H362 GHS05 H362 Acute Tox. 4 H332 Dgr H332 Acute Tox. 4 H302 H302 STOT RE 1 H372 (liver) H372 (liver) Eye Dam. 1 H318 H318 612-282-00-8 octadecylamine 204-695-3 124-30-1 Asp. Tox. 1 H304 GHS05 H304 M = 10 M = 10 STOT RE 2 H373 (gastro-intestinal tract, liver, immune system) GHS08 H373 (gastro-intestinal tract, liver, immune system) Skin Irrit. 2 H315 GHS09 H315 Eye Dam. 1 H318 Dgr H318 Aquatic Acute 1 H400 Aquatic Chronic 1 H410 H410 612-283-00-3 (Z)-octadec-9-enylamine 204-015-5 112-90-3 Acute Tox. 4 H302 GHS05 H302 M = 10 M = 10 Asp Tox. 1 H304 GHS07 H304 STOT SE 3 H335 GHS08 H335 STOT RE 2 H373 (gastro-intestinal tract, liver, immune system) GHS09 H373 (gastro-intestinal tract, liver, immune system) Skin Corr. 1B H314 Dgr H314 Aquatic Acute 1 H400 Aquatic Chronic 1 H410 H410 612-284-00-9 amines, hydrogenated tallow alkyl 262-976-6 61788-45-2 Asp Tox. 1 H304 GHS08 H304 M = 10 M = 10 STOT RE 2 H373 (gastro-intestinal tract, liver, immune system) GHS05 H373 (gastro-intestinal tract, liver, immune system) Skin Irrit. 2 H315 GHS09 H315 Eye Dam. 1 H318 Dgr H318 Aquatic Acute 1 H400 Aquatic Chronic 1 H410 H410 612-285-00-4 amines, coco alkyl 262-977-1 61788-46-3 Acute Tox. 4 H302 GHS05 H302 M = 10 M = 10 Asp. Tox. 1 H304 GHS07 H304 STOT SE 3 H335 GHS08 H335 STOT RE 2 H373 (gastro-intestinal tract, liver, immune system) GHS09 H373 (gastro-intestinal tract, liver, immune system) Skin Corr. 1B H314 Dgr H314 Aquatic Acute 1 H400 Aquatic Chronic 1 H410 H410 612-286-00-X amines, tallow alkyl 263-125-1 61790-33-8 Acute Tox. 4 H302 GHS05 H302 M = 10 M = 10 Asp. Tox. 1 H304 GHS07 H304 STOT RE 2 H373 (gastro-intestinal tract, liver, immune system) GHS08 H373 (gastro-intestinal tract, liver, immune system) Skin Corr. 1B H314 GHS09 H314 Aquatic Acute 1 H400 Dgr Aquatic Chronic 1 H410 H410 616-206-00-4 flufenoxuron (ISO); 1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea 417-680-3 101463-69-8 Lact. H362 GHS09 H362 M = 10 000 M = 10 000 Aquatic Acute 1 H400 Wng Aquatic Chronic 1 H410 H410 616-207-00-X polyhexamethylene biguanide hydrochloride 27083-27-8 or 32289-58-0 Carc. 2 H351 GHS05 H351 M = 10 M = 10 Acute Tox. 4 H302 GHS07 H302 STOT RE 1 H372 (respiratory tract) (inhalation) GHS08 H372 (respiratory tract) (inhalation) Eye Dam. 1 H318 GHS09 H318 Skin Sens. 1B H317 Dgr H317 Aquatic Acute 1 H400 Aquatic Chronic 1 H410 H410 616-208-00-5 N-ethyl-2-pyrrolidone; 1-ethylpyrrolidin-2-one 220-250-6 2687-91-4 Repr. 1B H360D GHS08 Dgr H360D 616-209-00-0 amidosulfuron (ISO); 3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea 407-380-0 120923-37-7 Aquatic Acute 1 H400 GHS09 M = 100 M = 100 Aquatic Chronic 1 H410 Wng H410 616-210-00-6 tebufenpyrad (ISO); N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5- carboxamide 119168-77-3 Acute Tox. 3 H301 GHS06 H301 M = 10 M = 10 Acute Tox. 4 H332 GHS08 H332 STOT RE 2 H373 (gastro-intestinal tract) (Oral) GHS09 H373 (gastro-intestinal tract) (Oral) Skin Sens. 1B H317 Dgr H317 Aquatic Acute 1 H400 Aquatic Chronic 1 H410 H410 616-211-00-1 proquinazid (ISO); 6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one 189278-12-4 Carc. 2 H351 GHS08 H351 M = 1 M = 10 Aquatic Acute 1 H400 GHS09 Aquatic Chronic 1 H410 Wng H410

ANNEX IV Index No International Chemical Identification EC No CAS No Classification Labelling Concentration Limits Notes 015-004-00-8 aluminium phosphide 244-088-0 20859-73-8 F; R15/29 T+; R26/28 Xn; R21 R32 N; R50 F; T+; N R: 15/29-21-26/28-32-50 S: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61 N; R50: C ≥ 0,25 % 015-005-00-3 magnesium phosphide; trimagnesium diphosphide 235-023-7 12057-74-8 F; R15/29 T+; R26/28 Xn; R21 R32 N; R50 F; T+; N R: 15/29-21-26/28-32-50 S: (1/2-)3/9/14/49-8-22-30-36/37-43-45-60-61 N; R50: C ≥ 0,25 % 015-123-00-5 fenamiphos (ISO); ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate 244-848-1 22224-92-6 T+; R26/28 T; R24 Xi; R36 N; R50-53 T+; N R: 24-26/28-36-50/53 S: (1/2-)23-26-28-35-36/37-45-60-61 N; R50-53: C ≥ 0,25 % N; R51-53: 0,025 % ≤ C < 0,25 % R52-53: 0,0025 % ≤ C < 0,025 % 030-012-00-1 aluminium-magnesium-zinc-carbonate-hydroxide 423-570-6 169314-88-9 R53 R: 53 S: 61 602-006-00-4 chloroform; trichloromethane 200-663-8 67-66-3 Carc. Cat. 3; R40 Repr. Cat. 3; R63 Xn; R20/22-48/20 Xi; R36/38 Xn R: 20/22-36/38-40-48/20-63 S: (2-)36/37 603-097-00-3 1,1′,1′′-nitrilotripropan-2-ol; triisopropanolamine 204-528-4 122-20-3 Xi; R36 Xi R: 36 S: (2-)26 605-008-00-3 acrolein; prop-2-enal; acrylaldehyde 203-453-4 107-02-8 F; R11 T+; R26/28 T; R24 C; R34 N; R50 F; T+; N R: 11-24-26/28-34-50 S: (1/2-)23-26-28-36/37/39-45-61 C; R34: C ≥ 0,1 % N; R50: C ≥ 0,25 % D 607-023-00-0 vinyl acetate 203-545-4 108-05-4 F; R11 Carc. Cat. 3; R40 Xn; R20 Xi; R37 F; Xn R: 11-20-37-40 S: 9-16-33-36/37 D 607-613-00-8 reaction mass of: succinic acid monopersuccinic acid dipersuccinic acid monomethyl ester of succinic acid monomethyl ester of persuccinic acid dimethyl succinate glutaric acid monoperglutaric acid diperglutaric acid monomethyl ester of glutaric acid monomethyl ester of perglutaric acid dimethyl glutarate adipic acid monoperadipic acid diperadipic acid monomethyl ester of adipic acid monomethyl ester of peradipic acid dimethyl adipate hydrogen peroxide methanol water 432-790-1 C; R34 Xn; R20/21/22-68/20/21/22 C R: 20/21/22-34-68/20/21/22 S: (1/2-)26-28-36/37/39-45 609-003-00-7 nitrobenzene 202-716-0 98-95-3 Carc. Cat. 3; R40 Repr. Cat. 2; R60 T; R23/24/25-48/23/24/25 R52-53 T R: 23/24/25-48/23/24/25-40-60-52/53 S: 45-53 612-120-00-6 aclonifen (ISO); 2-chloro-6-nitro-3-phenoxyaniline 277-704-1 74070-46-5 Carc. Cat. 3; R40 R43 N; R50-53 Xn; N R: 40-43-50/53 S: (2-)36/37-60-61 R43: C ≥ 0,1 % N; R50-53: C ≥ 0,25 % N; R51-53: 0,025 % ≤ C < 0,25 % R52-53: 0,0025 % ≤ C < 0,025 % 613-175-00-9 epoxiconazole (ISO); (2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane 406-850-2 133855-98-8 Carc. Cat. 3; R40 Repr. Cat. 2; R61 Repr. Cat. 3; R62 N; R51-53 T; N R: 61-40-62-51/53 S: 45-53-61 616-200-00-1 reaction mass of N,N’-ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide) 432-430-3 R53 R: 53 S: 61 648-055-00-5 pitch, coal tar, high-temp.; [The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] 266-028-2 65996-93-2 Carc. Cat. 1; R45 Muta. Cat. 2; R46 Repr. Cat. 2; R60-61 N; R50-53 T; N R: 45-46-60-61-50/53 S: 45-53-60-61 N; R50-53: C ≥ 0,025 % N; R51-53: 0,0025 % ≤ C < 0,025 % R52-53: 0,00025 % ≤ C < 0,0025 % 649-330-00-2 naphtha (petroleum), hydrodesulphurized heavy; Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).] 265-185-4 64742-82-1 Carc. Cat. 2; R45 Muta. Cat. 2; R46 Xn; R48/20-65 T R: 45-46-48/20-65 S: 45-53 P 649-345-00-4 stoddard solvent; Low boiling point naphtha — unspecified; [A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).] 232-489-3 8052-41-3 Carc. Cat. 2; R45 Muta. Cat. 2; R46 Xn; R48/20-65 T R: 45-46-48/20-65 S: 45-53 P 649-405-00-X solvent naphtha (petroleum), medium aliph.; Straight run kerosine; [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).] 265-191-7 64742-88-7 Xn; R48/20-65 Xn R: 48/20-65 S: (2-)23-24-62